In the present study, we found that the overexpression of the LMNA gene could discriminate GBM patients with a poorer prognosis, specifically in tumours belonging to Classical, Neural and Proneural but not in Mesenchymal GBM subtypes. This evidence concerns the gene LMNA and neoplasm.